FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048602102> ?p ?o ?g. }

• W2048602102 endingPage "e007700" @default.
• W2048602102 startingPage "e007700" @default.
• W2048602102 abstract "Liver disease mortality and morbidity are rapidly rising and liver transplantation is limited by organ availability. Small scale human studies have shown that stem cell therapy is safe and feasible and has suggested clinical benefit. No published studies have yet examined the effect of stem cell therapy in a randomised controlled trial and evaluated the effect of repeated therapy.Patients with liver cirrhosis will be randomised to one of three trial groups: group 1: Control group, Standard conservative management; group 2 treatment: granulocyte colony-stimulating factor (G-CSF; lenograstim) 15 µg/kg body weight daily on days 1-5; group 3 treatment: G-CSF 15 µg/kg body weight daily on days 1-5 followed by leukapheresis, isolation and aliquoting of CD133+ cells. Patients will receive an infusion of freshly isolated CD133+ cells immediately and frozen doses at days 30 and 60 via peripheral vein (0.2×10(6) cells/kg for each of the three doses). Primary objective is to demonstrate an improvement in the severity of liver disease over 3 months using either G-CSF alone or G-CSF followed by repeated infusions of haematopoietic stem cells compared with standard conservative management. The trial is powered to answer two hypotheses of each treatment compared to control but not powered to detect smaller expected differences between the two treatment groups. As such, the overall α=0.05 for the trial is split equally between the two hypotheses. Conventionally, to detect a relevant standardised effect size of 0.8 point reduction in Model for End-stage Liver Disease score using two-sided α=0.05(overall α=0.1 split equally between the two hypotheses) and 80% power requires 27 participants to be randomised per group (81 participants in total).The trial is registered at Current Controlled Trials on 18 November 2009 (ISRCTN number 91288089, EuDRACT number 2009-010335-41). The findings of this trial will be disseminated to patients and through peer-reviewed publications and international presentations." @default.
• W2048602102 created "2016-06-24" @default.
• W2048602102 creator A5014784239 @default.
• W2048602102 creator A5023057149 @default.
• W2048602102 creator A5028677250 @default.
• W2048602102 creator A5029579495 @default.
• W2048602102 creator A5037453305 @default.
• W2048602102 creator A5038569452 @default.
• W2048602102 creator A5044832887 @default.
• W2048602102 creator A5046346164 @default.
• W2048602102 creator A5053544264 @default.
• W2048602102 creator A5054345445 @default.
• W2048602102 creator A5061369170 @default.
• W2048602102 creator A5066381179 @default.
• W2048602102 creator A5070461470 @default.
• W2048602102 creator A5073720777 @default.
• W2048602102 creator A5085479412 @default.
• W2048602102 date "2015-03-20" @default.
• W2048602102 modified "2023-09-27" @default.
• W2048602102 title "REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial" @default.
• W2048602102 cites W1532162953 @default.
• W2048602102 cites W1542326554 @default.
• W2048602102 cites W1964051982 @default.
• W2048602102 cites W1964720896 @default.
• W2048602102 cites W1979121245 @default.
• W2048602102 cites W1982022033 @default.
• W2048602102 cites W1985534351 @default.
• W2048602102 cites W1993065115 @default.
• W2048602102 cites W2002391829 @default.
• W2048602102 cites W2013502482 @default.
• W2048602102 cites W2023299094 @default.
• W2048602102 cites W2024941047 @default.
• W2048602102 cites W2030635697 @default.
• W2048602102 cites W2031885111 @default.
• W2048602102 cites W2033977098 @default.
• W2048602102 cites W2034885353 @default.
• W2048602102 cites W2054857478 @default.
• W2048602102 cites W2061360375 @default.
• W2048602102 cites W2069243984 @default.
• W2048602102 cites W2071904364 @default.
• W2048602102 cites W2074246682 @default.
• W2048602102 cites W2080512694 @default.
• W2048602102 cites W2090504602 @default.
• W2048602102 cites W2101099470 @default.
• W2048602102 cites W2111335059 @default.
• W2048602102 cites W2115268377 @default.
• W2048602102 cites W2133860937 @default.
• W2048602102 cites W2142907317 @default.
• W2048602102 cites W2143468834 @default.
• W2048602102 cites W2150640796 @default.
• W2048602102 cites W2151769300 @default.
• W2048602102 cites W2159114947 @default.
• W2048602102 cites W2162322495 @default.
• W2048602102 cites W2167738407 @default.
• W2048602102 cites W2169441556 @default.
• W2048602102 cites W2322084576 @default.
• W2048602102 cites W2333113641 @default.
• W2048602102 cites W64471759 @default.
• W2048602102 doi "https://doi.org/10.1136/bmjopen-2015-007700" @default.
• W2048602102 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4368910" @default.
• W2048602102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25795699" @default.
• W2048602102 hasPublicationYear "2015" @default.
• W2048602102 type Work @default.
• W2048602102 sameAs 2048602102 @default.
• W2048602102 citedByCount "28" @default.
• W2048602102 countsByYear W20486021022015 @default.
• W2048602102 countsByYear W20486021022016 @default.
• W2048602102 countsByYear W20486021022017 @default.
• W2048602102 countsByYear W20486021022018 @default.
• W2048602102 countsByYear W20486021022019 @default.
• W2048602102 countsByYear W20486021022020 @default.
• W2048602102 countsByYear W20486021022021 @default.
• W2048602102 countsByYear W20486021022023 @default.
• W2048602102 crossrefType "journal-article" @default.
• W2048602102 hasAuthorship W2048602102A5014784239 @default.
• W2048602102 hasAuthorship W2048602102A5023057149 @default.
• W2048602102 hasAuthorship W2048602102A5028677250 @default.
• W2048602102 hasAuthorship W2048602102A5029579495 @default.
• W2048602102 hasAuthorship W2048602102A5037453305 @default.
• W2048602102 hasAuthorship W2048602102A5038569452 @default.
• W2048602102 hasAuthorship W2048602102A5044832887 @default.
• W2048602102 hasAuthorship W2048602102A5046346164 @default.
• W2048602102 hasAuthorship W2048602102A5053544264 @default.
• W2048602102 hasAuthorship W2048602102A5054345445 @default.
• W2048602102 hasAuthorship W2048602102A5061369170 @default.
• W2048602102 hasAuthorship W2048602102A5066381179 @default.
• W2048602102 hasAuthorship W2048602102A5070461470 @default.
• W2048602102 hasAuthorship W2048602102A5073720777 @default.
• W2048602102 hasAuthorship W2048602102A5085479412 @default.
• W2048602102 hasBestOaLocation W20486021021 @default.
• W2048602102 hasConcept C10205521 @default.
• W2048602102 hasConcept C109159458 @default.
• W2048602102 hasConcept C126322002 @default.
• W2048602102 hasConcept C141071460 @default.
• W2048602102 hasConcept C168563851 @default.
• W2048602102 hasConcept C2776694085 @default.
• W2048602102 hasConcept C2777214474 @default.
• W2048602102 hasConcept C2777371436 @default.

• next